Meyronet, D
427  results:
Search for persons X
?
3

OS02.6.A The TeloDIAG: How telomeric parameters can help in..:

Billard, P ; Guerriau, C ; Carpentier, C...
Neuro-Oncology.  23 (2021)  Supplement_2 - p. ii5-ii6 , 2021
 
?
4

KS02.4.A Olaparib in Recurrent IDH-mutant High-Grade Glioma..:

Ducray, F ; Sanson, M ; Chinot, O...
Neuro-Oncology.  23 (2021)  Supplement_2 - p. ii4-ii4 , 2021
 
?
6

P14.12 Gyriform infiltration as imaging biomarker for adult..:

Mesny, E ; Barritault, M ; Izquierdo, C...
Neuro-Oncology.  23 (2021)  Supplement_2 - p. ii40-ii40 , 2021
 
?
7

OS02.4.A Molecular characterization of adult cerebellar gli..:

Picart, T ; Poncet, D ; Barritault, M...
Neuro-Oncology.  23 (2021)  Supplement_2 - p. ii5-ii5 , 2021
 
?
 
?
9

P13.02 Conventional MRI radiomics in the diagnosis of early..:

Bani Sadr, A ; Eker, O F ; Berner, L...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii62-iii62 , 2019
 
?
11

OS8.4 Impact of brain invasion assessment on outcome in int..:

Picart, T ; Dumot, C ; Ducray, F...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii16-iii16 , 2019
 
?
12

P14.13 Incidence of pseudoprogression in high-grade IDH-mut..:

SEYVE, A ; Cartalat, S ; Meyronet, D...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii69-iii69 , 2019
 
?
 
?
14

OS5.5 Characteristics of high-grade gliomas with H3 G34 mut..:

Picart, T ; Barritault, M ; Tabouret, E...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii12-iii12 , 2019
 
?
15

P14.88 Comparison of SNaPshot PCR and digital droplet PCR f..:

Poncet, D ; Picart, T ; Guyotat, J...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii88-iii88 , 2019
 
1-15